Your browser doesn't support javascript.
Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain.
Roso-Llorach, Albert; Serra-Picamal, Xavier; Cos, Francesc X; Pallejà-Millán, Meritxell; Mateu, Lourdes; Rosell, Antoni; Almirante, Benito; Ferrer, Jaume; Gasa, Mercè; Gudiol, Carlota; Moreno, Anna Maria; Morales-Rull, Jose Luís; Rexach, Maria; Sabater, Gladis; Auguet, Teresa; Vidal, Francesc; Lerida, Ana; Rebull, Josep; Khunti, Kamlesh; Argimon, Josep M; Paredes, Roger.
  • Roso-Llorach A; Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gorina (IDIAPJGol), Barcelona, Catalonia, Spain.
  • Serra-Picamal X; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain.
  • Cos FX; Institut Català de la Salut (ICS), Barcelona, Catalonia, Spain.
  • Pallejà-Millán M; Institut Català de la Salut (ICS), Barcelona, Catalonia, Spain.
  • Mateu L; Unitat de Suport a la Recerca Tarragona-Reus, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Reus, Catalonia, Spain.
  • Rosell A; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain.
  • Almirante B; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.
  • Ferrer J; Universitat de Vic-UCC, Vic, Catalonia, Spain.
  • Gasa M; CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
  • Gudiol C; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain.
  • Moreno AM; CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
  • Morales-Rull JL; Department of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.
  • Rexach M; Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Catalonia, Spain.
  • Sabater G; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain.
  • Auguet T; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Vidal F; Spanish Network for Research in Infectious Disease (REIPI), Instituto de Salud Carlos III, Madrid, Spain.
  • Lerida A; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Catalonia, Spain.
  • Rebull J; CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
  • Khunti K; Department of Respiratory Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Argimon JM; Department of Respiratory Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, Catalonia, Spain.
  • Paredes R; Institut d'investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Catalonia, Spain.
Glob Epidemiol ; 4: 100071, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-1611740
ABSTRACT

BACKGROUND:

The changes in shield strategies, treatments, emergence variants, and healthcare pathways might shift the profile and outcome of patients hospitalized with COVID-19 in successive waves of the outbreak.

METHODS:

We retrospectively analysed the characteristics and in-hospital outcomes of all patients admitted with COVID-19 in eight university hospitals of Catalonia (North-East Spain) between Feb 28, 2020 and Feb 28, 2021. Using a 7-joinpoint regression analysis, we split admissions into four waves. The main hospital outcomes included 30-day mortality and admission to intensive care unit (ICU).

FINDINGS:

The analysis included 17,027 subjects admitted during the first wave (6800; 39.9%), summer wave (1807; 10.6%), second wave (3804; 22.3%), and third wave (4616; 27.1%). The highest 30-day mortality rate was reported during the first wave (17%) and decreased afterwards, remaining stable at 13% in the second and third waves (overall 30% reduction); the lowest mortality was reported during the summer wave (8%, 50% reduction). ICU admission became progressively more frequent during successive waves. In Cox regression analysis, the main factors contributing to differences in 30-day mortality were the epidemic wave, followed by gender, age, diabetes, chronic kidney disease, and neoplasms.

INTERPRETATION:

Although in-hospital COVID-19 mortality remains high, it decreased substantially after the first wave and is highly dependent of patient's characteristics and ICU availability. Highest mortality reductions occurred during a wave characterized by younger individuals, an increasingly frequent scenario as vaccination campaigns progress.

FUNDING:

This work did not receive specific funding.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines / Variants Language: English Journal: Glob Epidemiol Year: 2022 Document Type: Article Affiliation country: J.gloepi.2022.100071

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines / Variants Language: English Journal: Glob Epidemiol Year: 2022 Document Type: Article Affiliation country: J.gloepi.2022.100071